Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Khoo SH., FitzGerald R., Saunders G., Middleton C., Ahmad S., Edwards CJ., Hadjiyiannakis D., Walker L., Lyon R., Shaw V., Mozgunov P., Periselneris J., Woods C., Bullock K., Hale C., Reynolds H., Downs N., Ewings S., Buadi A., Cameron D., Edwards T., Knox E., Donovan-Banfield I., Greenhalf W., Chiong J., Lavelle-Langham L., Jacobs M., Northey J., Painter W., Holman W., Lalloo DG., Tetlow M., Hiscox JA., Jaki T., Fletcher T., Griffiths G., Paton N., Hayden F., Darbyshire J., Lucas A., Lorch U., Freedman A., Knight R., Julious S., Byrne R., Cubas Atienzar A., Jones J., Williams C., Song A., Dixon J., Alexandersson A., Hatchard P., Tilt E., Titman A., Doce Carracedo A., Chandran Gorner V., Davies A., Woodhouse L., Carlucci N., Okenyi E., Bula M., Dodd K., Gibney J., Dry L., Rashid Gardner Z., Sammour A., Cole C., Rowland T., Tsakiroglu M., Yip V., Osanlou R., Stewart A., Parker B., Turgut T., Ahmed A., Starkey K., Subin S., Stockdale J., Herring L., Baker J., Oliver A., Pacurar M., Owens D., Munro A., Babbage G., Faust S., Harvey M., Pratt D., Nagra D., Vyas A.

DOI

10.1016/s1473-3099(22)00644-2

Type

Journal article

Publisher

Elsevier BV

Publication Date

2023-02-01T00:00:00+00:00

Volume

23

Pages

183 - 195

Total pages

12

Permalink More information Close